BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 32215773)

  • 1. Transdermal Delivery of the Free Base of 3-Fluoroamphetamine: In Vitro Skin Permeation and Irritation Potential.
    Jiang Y; Murnane KS; Blough BE; Banga AK
    AAPS PharmSciTech; 2020 Mar; 21(3):109. PubMed ID: 32215773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skin Delivery and Irritation Potential of Phenmetrazine as a Candidate Transdermal Formulation for Repurposed Indications.
    Jiang Y; Murnane KS; Bhattaccharjee SA; Blough BE; Banga AK
    AAPS J; 2019 May; 21(4):70. PubMed ID: 31152318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of chemical and physical enhancement techniques on transdermal delivery of 3-fluoroamphetamine hydrochloride.
    Puri A; Murnane KS; Blough BE; Banga AK
    Int J Pharm; 2017 Aug; 528(1-2):452-462. PubMed ID: 28633107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transdermal delivery of nicardipine: an approach to in vitro permeation enhancement.
    Aboofazeli R; Zia H; Needham TE
    Drug Deliv; 2002; 9(4):239-47. PubMed ID: 12511202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pharmacokinetics of 3-fluoroamphetamine following delivery using clinically relevant routes of administration.
    Jiang Y; Ray A; Junaid MSA; Bhattaccharjee SA; Kelley K; Banga AK; Blough BE; Murnane KS
    Drug Deliv Transl Res; 2020 Feb; 10(1):271-281. PubMed ID: 31642004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Passive and active strategies for transdermal delivery using co-encapsulating nanostructured lipid carriers: in vitro vs. in vivo studies.
    Vitorino C; Almeida A; Sousa J; Lamarche I; Gobin P; Marchand S; Couet W; Olivier JC; Pais A
    Eur J Pharm Biopharm; 2014 Feb; 86(2):133-44. PubMed ID: 24333401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of permeation enhancers on transdermal delivery of fluoxetine: in vitro and in vivo evaluation.
    Jung E; Kang YP; Yoon IS; Kim JS; Kwon SW; Chung SJ; Shim CK; Kim DD
    Int J Pharm; 2013 Nov; 456(2):362-9. PubMed ID: 24012861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural oils as skin permeation enhancers for transdermal delivery of olanzapine: in vitro and in vivo evaluation.
    Aggarwal G; Dhawan S; HariKumar SL
    Curr Drug Deliv; 2012 Mar; 9(2):172-81. PubMed ID: 22023211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transdermal delivery of a pineal hormone: melatonin via elastic liposomes.
    Dubey V; Mishra D; Asthana A; Jain NK
    Biomaterials; 2006 Jun; 27(18):3491-6. PubMed ID: 16513163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feasibility of transdermal delivery of fluoxetine.
    Parikh DK; Ghosh TK
    AAPS PharmSciTech; 2005 Sep; 6(2):E144-9. PubMed ID: 16353971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and in vitro evaluation of pressure sensitive adhesive patch for the transdermal delivery of galantamine: Effect of penetration enhancers and crystallization inhibition.
    Ameen D; Michniak-Kohn B
    Eur J Pharm Biopharm; 2019 Jun; 139():262-271. PubMed ID: 30981946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transdermal delivery of ketorolac.
    Amrish C; Kumar SP
    Yakugaku Zasshi; 2009 Mar; 129(3):373-9. PubMed ID: 19252396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transdermal Delivery of Cimetidine Across Microneedle-Treated Skin: Effect of Extent of Drug Ionization on the Permeation.
    Song Y; Herwadkar A; Patel MG; Banga AK
    J Pharm Sci; 2017 May; 106(5):1285-1292. PubMed ID: 28161442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A combination of nonionic surfactants and iontophoresis to enhance the transdermal drug delivery of ondansetron HCl and diltiazem HCl.
    Silva SM; Hu L; Sousa JJ; Pais AA; Michniak-Kohn BB
    Eur J Pharm Biopharm; 2012 Apr; 80(3):663-73. PubMed ID: 22137964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transdermal delivery of human growth hormone via laser-generated micropores.
    Song Y; Hemmady K; Puri A; Banga AK
    Drug Deliv Transl Res; 2018 Apr; 8(2):450-460. PubMed ID: 28321676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formulation study of a patch containing propranolol by design of experiments.
    Cilurzo F; Minghetti P; Gennari CG; Casiraghi A; Selmin F; Montanari L
    Drug Dev Ind Pharm; 2014 Jan; 40(1):17-22. PubMed ID: 23301830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Permeation enhancers in transdermal drug delivery: benefits and limitations.
    Kováčik A; Kopečná M; Vávrová K
    Expert Opin Drug Deliv; 2020 Feb; 17(2):145-155. PubMed ID: 31910342
    [No Abstract]   [Full Text] [Related]  

  • 18. Poly (vinyl alcohol) microneedles: Fabrication, characterization, and application for transdermal drug delivery of doxorubicin.
    Nguyen HX; Bozorg BD; Kim Y; Wieber A; Birk G; Lubda D; Banga AK
    Eur J Pharm Biopharm; 2018 Aug; 129():88-103. PubMed ID: 29800617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of skin permeation of bufalin by limonene via reservoir type transdermal patch: formulation design and biopharmaceutical evaluation.
    Yang Z; Teng Y; Wang H; Hou H
    Int J Pharm; 2013 Apr; 447(1-2):231-40. PubMed ID: 23467076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Mild Hyperthermia on Transdermal Absorption of Nicotine from Patches.
    Panda A; Sharma PK; Narasimha Murthy S
    AAPS PharmSciTech; 2019 Jan; 20(2):77. PubMed ID: 30635802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.